---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-091874"
form_type: "8-K"
ticker: null
cik: "0001584751"
company_name: "Talis Biomedical Corp"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:16:26.312059+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Talis Biomedical adds restructuring directors, authorizes potential Ch. 11 filing

## Summary
- Director Heinrich Dreismann resigned effective Aug 1, 2024; Patricia Ferrari and John T. Young Jr. elected.
- New Special Restructuring Committee (Ferrari, Young) authorized to settle securities class action, file Ch. 11, and investigate officer/director claims.
- Ferrari and Young each receive $35,000/month guaranteed for at least 6 months or until bankruptcy plan confirmed.
- Young receives $10,000/yr as Audit Committee chair; both have deep bankruptcy and liquidation experience.

## SEC filing metadata
- accession: 0000950170-24-091874
- form_type: 8-K
- cik: 0001584751
- company_name: Talis Biomedical Corp
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1584751/000095017024091874/0000950170-24-091874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1584751/000095017024091874/tlis-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-091874
- JSON: https://secwatch.observer/filing/0000950170-24-091874.json
- Plain text: https://secwatch.observer/filing/0000950170-24-091874.txt

## Key facts
- Executive change
  Heinrich Dreismann resigned as Director at Talis Biomedical Corp.
  - Action: resigned
  - Role: Director
  source text: Accepting the voluntary resignation of Heinrich Dreismann from the Board effective August 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1584751/000095017024091874/0000950170-24-091874-index.htm
- Executive change
  John T. Young, Jr. was elected as Director at Talis Biomedical Corp.
  - Action: elected
  - Role: Director
  source text: Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1584751/000095017024091874/0000950170-24-091874-index.htm
- Executive change
  Patricia Ferrari was elected as Director at Talis Biomedical Corp.
  - Action: elected
  - Role: Director
  source text: Electing each of Patricia Ferrari and John T. Young, Jr. to the Board effective July 31, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1584751/000095017024091874/0000950170-24-091874-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.